Zimbabwe has declined a significant American healthcare agreement worth $367m (272 million pounds) spanning five years because of the United States' insistence on confidential biological samples.
This move came to light after a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesperson later stated that the US was requesting genetic material for research and profit but was unwilling to guarantee the benefits from any future treatments.
"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more negotiations to reach a agreement suitable to all parties so the country's vital HIV programme can proceed.
Broader Background
Zimbabwe's decision comes after a comparable case in Kenya, where a high court blocked a similar deal with the US after legal challenges were raised about the security of citizens' health data.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and responsibility.
Based on reports, 16 nations in Africa have to date agreed to these new health pacts, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no corresponding guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would provide the raw materials for scientific discovery without any certainty that the end products would be accessible to our people if a future pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks previously established through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This framework is designed to guarantee that when a country provides its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We are open to ongoing dialogue with our US partners on how subsequent collaboration might be arranged in a way that respects the sovereignty and dignity of both nations."
Health Experts Response
A leading public health body stated it recognised the official position, but urged that negotiations must proceed given that much of the country's HIV programmes were funded by foreign aid.
"In cases where specific concerns arise, such as those involving information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group added.
The situation highlights the continuing debate between accepting vital international aid and protecting local interests in an increasingly interconnected world.